Contact us
Let us know about your remote blood biomarker monitoring needs.
50 Milk Street
16th floor
Boston, MA 02109
contact@generalprognostics.com
A bloodless future for healthcare?
Blood tests are the gold standard for predicting disease progression. Unfortunately, blood tests may also be time consuming, expensive, and painful.
What if your smartwatch
could tell you
When vital blood biomarkers change?
Our Purpose
GPx is enhancing remote patient management by building a new class of biomarkers called Bloodless Blood Tests. Through our AI-powered Canary Prediction Engine, digital biomarkers collected from patient wearables and peripherals transform into an unparalleled window into patient blood biomarker status. With this data, physicians benefit from presymptomatic detection of critical patient condition changes, enabling timely treatment that avoids hospital readmissions.
LEARN MORE ABOUT OUR TECHNOLOGY
Our News
Find out the latest on GPx
One of GPx's Co-Founders, Javier Echenique got the privilege to be interviewed by #Sony Startup Acceleration Program. Check out the full interview here: https://lnkd.in/eHSj8fne
.@bostonsci is delighted to announce the Connected Patient Challenge VI Pitch Off on Thurs, Aug 12 at 12noon Eastern Time. Finalists are @GPx_Boston @valhallahealth #VoiceLove @iTetherTech @KaliaHealth. Register here - https://bsci-nm.zoom.us/webinar/register/WN_JckAQo_JS4u93Lxgpx2epQ
#CPCVI
Please join us on August 12th as we present #CardioID's #Bloodlessbloodtest at the #BostonScientific Connected Patient Challenge Pitch-Off: Improving Patient Care & Connectivity while Closing the Gap in Healthcare Disparities – #Telehealth.
https://www.linkedin.com/posts/jenniferjoemd_welcome-you-are-invited-to-join-a-webinar-activity-6826876500147544064-rZ_G